INTERPARFUMS INC IPAR
Nasdaq · XNAS · stock · Perfumes, Cosmetics & Other Toilet Preparations
Chart by TradingView
5/9
Piotroski F — financial health
8.09
Altman Z″ — distress risk · safe
61.0%
Dividend payout · stretched
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $1.5B | $168.4M | $947.2M | $190.5M | $1.1B |
| 2024 | $1.5B | $164.4M | $927.3M | $182.9M | $744.9M |
| 2023 | $1.3B | $152.7M | $839.1M | $99.3M | $892.2M |
| 2022 | $1.1B | $120.9M | $694.4M | $39.3M | $788.1M |
| 2021 | $879.5M | $87.4M | $556.9M | -$21.7M | $738.3M |
| 2020 | $539.0M | $38.2M | $330.7M | $54.0M | $702.5M |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 8.09 (safe)
- Working capital / assets 0.431
- Retained earnings / assets 0.523
- EBIT / assets 0.171
- Equity / liabilities 2.294
Source: SEC EDGAR filings · CIK 0000822663 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.